News from Visiopharm


Short Course on Quantitative Digital Pathology

October 23-27, 2017

Attend our Short Course on Quantitative Digital Pathology

Read more here

 

 

European Congress of Pathology - 2017

September 2-6, 2017

Meet us at the European Congress of Pathology 2017

Sign up here

View Abstracts from our speakers here

 

New APP: PD-L1 Melanoma

Programmed death-ligand 1 (PD-L1) is a transmembrane protein that binds to the inhibitory receptor programmed death 1 receptor (PD-1), causing a down regulation of immune responses. Tumor cells can upregulate PD-L1 expression and avoid being attacked by the body’s immune system, making an interruption of the PD-1/PD-L1 interaction an attractive method for assisting the immune system in destroying tumor cells.

For more information visit our APP Center

New APP: PD-L1 Lung Cancer

PD-L1 is typically expressed on normal cells but has been observed in immune cells and tumor cells while PD-1 is typically expressed on cytotoxic T-cells and other immune cells. Tumor cells can upregulate PD-L1 expression and avoid being attacked by the body’s immune system, making an interruption of the PD-1/PD-L1 interaction an attractive method for assisting the immune system in destroying tumor cells.

For more information visit our APP Center

Webinar: Advanced Virtual Multiplexing

By Dr. Regan Baird 

14 September 2017, 16:30 CET, 10:30 am EST, 7:30 am PST

Register here

Read the abstract here

Sign up to our newsletter

Visiopharm quantitative digital pathology solutions provide pathologists and scientists with a flexible, powerful suite of software to quantify relevant tissue properties in a fast, objective and reproducible way.

Learn more about us

Visit our APP center

The worlds largest and fastest growing

Visit the complete app center

Publications

Visiopharm software is featured in over 1100 international scientific publications. They are based on collaborations with leading scientists in hospitals, biopharmaceutical companies and research institutions around the world. Select a main category to access the publication list.